CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Abionyx Pharma SA Company Snapshot
Abionyx Pharma SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abionyx Pharma SA with three other miscellaneous service companies in Europe: SenzaGen AB of Sweden (2018 sales of 2.00 million Swedish Kronor [US$205,211.72 ] ), Xintela AB of Sweden (1.63 million Swedish Kronor [US$167,293.28 ] ), and Redx Pharma PLC which is based in the United Kingdom (£129,000.00 [US$165,810.15 ] of which 100% was pharmaceutical).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Abionyx Pharma SA
  Stock Performance Chart for Abionyx Pharma SA
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): .23
(Figures in Euro)
1 Week -1.1%   13 Weeks -14.3%  
4 Weeks -28.1%   52 Weeks -85.2%  
 
Abionyx Pharma SA Key Data:
  Ticker: ABNX Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 174,000
(Year Ending Jan 2019).
Employees: 14
  Currency: Euro Market Cap: 5,039,148
  Fiscal Yr Ends: December Shares Outstanding: 21,861,813
  Share Type: Actions Ordinaires Closely Held Shares: 1,434,587
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.